CORRECTION article

Front. Mol. Biosci., 09 May 2025

Sec. Cellular Biochemistry

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1601841

Corrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats

This article is a correction to:

  1. Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats

    1. Read original article
Maha Abdullah AlwailiMaha Abdullah Alwaili1Amal S. Abu-AlmakaremAmal S. Abu-Almakarem2Salwa AljohaniSalwa Aljohani3Sahar Abdulrahman AlkhodairSahar Abdulrahman Alkhodair4Maha M. Al-BaziMaha M. Al-Bazi4Thamir M. EidThamir M. Eid4Jehan AlamriJehan Alamri5Maysa A. MobasherMaysa A. Mobasher6Norah K. AlgarzaeNorah K. Algarzae7Arwa Ishaq A. KhayyatArwa Ishaq A. Khayyat8Luluah Saleh AlshaygyLuluah Saleh Alshaygy8Karim Samy El-Said Karim Samy El-Said9*
  • 1Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia
  • 2Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, Al-Baha University, Al Bahah, Saudi Arabia
  • 3Chemistry Department, Faculty of Science, Taibah University, Yanbu, Saudi Arabia
  • 4Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
  • 5Biology Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia
  • 6Department of Pathology, Biochemistry Division, College of Medicine, Jouf University, Sakaka, Saudi Arabia
  • 7Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia
  • 8Biochemistry Department, Science College, King Saud University, Riyadh, Saudi Arabia
  • 9Biochemistry Division, Chemistry Department, Faculty of Science, Tanta University, Tanta, Egypt

A Corrigendum on
Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-catenin pathways in male rats

by Alwaili MA, Abu-Almakarem AS, Aljohani S, Alkhodair SA, Al-Bazi MM, Eid TM, Alamri J, Mobasher MA, Algarzae NK, A. Khayyat AI, Alshaygy LS and El-Said KS (2024). Front. Mol. Biosci. 11:1507786. doi: 10.3389/fmolb.2024.1507786

In the published article, an Author Name was incorrectly written as Norah K. Algarza. The correct spelling is Norah K. Algarzae.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: avenanthramides, antioxidants, anti-inflammatory, doxorubicin, hepatotoxicity, signaling pathway

Citation: Alwaili MA, Abu-Almakarem AS, Aljohani S, Alkhodair SA, Al-Bazi MM, Eid TM, Alamri J, Mobasher MA, Algarzae NK, A. Khayyat AI, Alshaygy LS and El-Said KS (2025) Corrigendum: Avenanthramide-C ameliorate doxorubicin-induced hepatotoxicity via modulating Akt/GSK-3β and Wnt-4/β-Catenin pathways in male rats. Front. Mol. Biosci. 12:1601841. doi: 10.3389/fmolb.2025.1601841

Received: 28 March 2025; Accepted: 21 April 2025;
Published: 09 May 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Alwaili, Abu-Almakarem, Aljohani, Alkhodair, Al-Bazi, Eid, Alamri, Mobasher, Algarzae, A. Khayyat, Alshaygy and El-Said. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Karim Samy El-Said, a2FyZWVtLmFsaUBzY2llbmNlLnRhbnRhLmVkdS5lZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.